Lupin Limited
₹2,315.1-0.80%Apr 13, 3:45 PM IST
LUPIN•Health Technology•Pharmaceuticals: Other
Current Price
₹2,315.1-0.80%
Apr 13, 3:45 PM ISTMarket Cap₹1,06,646.18 Cr
Market Cap₹1,06,646.18 Cr
Business Overview
Lupin Limited operates through 8 main business divisions including Pharmaceuticals, Lupin Diagnostics, Lupin Digital Health, Atharv Ability, LupinLife Consumer Healthcare, API Plus, Research and Development (R&D), Global Institutional Business.
Business Hierarchy Structure for Lupin Limited
- Lupin Limited
- Pharmaceuticals
- Generics
- Branded Generics
- Complex Generics
- Biosimilars
- Specialty Medicines
- Therapeutic Areas
- Cardiovascular
- Diabetes Management
- Respiratory
- Gastrointestinal
- Anti-infective
- Central Nervous System
- Women’s Health
- Oncology
- Immunology
- Anti-diabetic
- Anti-infective
- Gastrointestinal
- Central Nervous System
- Women’s Health
- Anti-TB
- Neurology
- Ophthalmology
- Urology
- Pediatrics
- Key Products
- Tiotropium DPI (Gx Spiriva)
- Albuterol
- GaviLyte
- Suprep
- Xopenex®
- Brovana®
- Vilfuro-G
- Nalcrom
- Aarane
- Ondero
- Ondero Met
- Ranibizumab
- Etanercept
- Ezetimibe
- Eslicarbazepine
- Pirfenidone
- Desvenlafaxine
- Dapagliflozin
- Mirabegron
- DIFIZMA® DPI
- Softovac®
- Aptivate®
- Vimpro
- Vovilup
- Lupin Diagnostics
- Lupin Digital Health
- Atharv Ability
- LupinLife Consumer Healthcare
- OTC Business
- API Plus
- Active Pharmaceutical Ingredient (API) Business
- Lupin Manufacturing Solutions (LMS)
- Global Institutional Business
- API Contract Development and Manufacturing Operations (CDMO)
- Research and Development (R&D)
- Global Institutional Business
- Pharmaceuticals